Abstract Library

The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.

1

Comparing treatment options for large vessel vasculitis

Expert Rev Clin Immunol. 2022 Aug;18(8):793-805.doi: 10.1080/1744666X.2022.2092098. Epub 2022 Jun 29.

 

Federica Macaluso 1 2Chiara Marvisi 1 3Paola Castrignanò 1 3Nicolò Pipitone 1Carlo Salvarani 1 3

2

New developments in treatments for systemic vasculitis

Curr Opin Pharmacol. 2022 Jul 31;66:102270. doi: 10.1016/j.coph.2022.102270.Online ahead of print.

 

Sarah Goglin 1Sharon A Chung 2

3

Obinutuzumab as treatment for ANCA-associated vasculitis

Rheumatology (Oxford). 2022 Aug 30;61(9):3814-3817.doi: 10.1093/rheumatology/keab916.

 

Naomi A Amudala 1Sara Boukhlal 2Brittany Sheridan 3Carol A Langford 4Abdallah Geara 3Peter A Merkel 5Divi Cornec 2

4

Relationship Between Cerebrovascular Diseases and Vasculitis: A Cross-Sectional Nationwide Inpatient Study

Cureus. 2022 Jul 29;14(7):e27435. doi: 10.7759/cureus.27435. eCollection 2022 Jul.

 

Anusheel 1Johanna S Canenguez Benitez 2Sanobar Jaka 3Nikhita S Roshan 4Sravani Kommuru 5Samreen Ahmed 6Gagan Kaur 7Ninad Desai 8

5

What to Know About Biopsy Sampling and Pathology in Vasculitis?

Curr Rheumatol Rep. 2022 Sep;24(9):279-291. doi: 10.1007/s11926-022-01082-6.Epub 2022 Jul 27.

 

Chiara Marvisi # 1 2Francesco Muratore # 3Chiara Cabassi 1 2Elena Galli 1 2Luigi Boiardi 1Simonetta Piana 4Maria Cecilia Mengoli 4Carlo Salvarani 1 2Alberto Cavazza 4

6

Added value of Joint ENT-Rheumatology clinic in the management of ANCA-associated vasculitis: One year's experience

Am J Otolaryngol. 2022 Jul-Aug;43(4):103485. doi: 10.1016/j.amjoto.2022.103485.Epub 2022 May 5.

 

M Stavrakas 1R Smith 2M Akil 2K-P Kuet 2F Morley 3J Ray 3

7

Treatment Guidelines in Vasculitis

Rheum Dis Clin North Am. 2022 Aug;48(3):705-724. doi: 10.1016/j.rdc.2022.03.006.Epub 2022 Jul 5.

 

Tanaz A Kermani 1Kenneth J Warrington 2Anisha B Dua 3

8

Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

JAMA Netw Open. 2022 Jul 1;5(7):e2220925.doi: 10.1001/jamanetworkopen.2022.20925.

 

Sara Thietart 1 2Alexandre Karras 3Jean-François Augusto 4Carole Philipponnet 5Pierre-Louis Carron 6Xavier Delbrel 7Rafik Mesbah 8Gilles Blaison 9Pierre Duffau 10Khalil El Karoui 11Perrine Smets 12Jonathan London 1 13Luc Mouthon 1 14Loïc Guillevin 1 14Benjamin Terrier 1 14Xavier Puéchal 1 14French Vasculitis Study Group

 

Collaborators

French Vasculitis Study Group: 

Asma AllaVincent AudardOlivier AumaîtreStéphane BallyBernard BonnottePierre CharlesPascal CohenAlice CorbelMaud CousinYoann CabrolStéphane DuruptBenoit FaucherSégolène GendreauNicolas GirszynPascal GodmerMohamed HamidouNoémie Jourde-ChicheAdeline LacrazCédric LandronClaire Le JeunneFrançois LifermannEric LiozonSylvain Marchand-AdamFrançois MaurierArsène MékinianChristian PagnouxThomas QuéméneurViviane QueyrelHanta Nirina RakotoariveloAlexis RégentQuitterie ReynaudVirginie RieuKarim SacreAndré SotoDimitri Titeca-BeauportStéphane Vinzio

9

Pediatric cardiothoracic vasculitis: multimodality imaging review

Pediatr Radiol. 2022 Jul 6;1-15. doi: 10.1007/s00247-022-05431-6.Online ahead of print.

 

Evan J Zucker 1Frandics P Chan 2

10

Practice patterns and outcomes for pediatric ANCA vasculitis transplant recipients in a national cohort

Pediatr Nephrol. 2022 Jul;37(7):1667-1673. doi: 10.1007/s00467-021-05341-z.Epub 2021 Nov 18.

 

Stella Kilduff 1Jonathan Butler 2Hiroshi Sogawa 3Sonia Solomon 4

11

New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension

Rheumatology (Oxford). 2022 Jul 6;61(7):2915-2922.doi: 10.1093/rheumatology/keab780.

 

John H Stone 1Helen Spotswood 2Sebastian H Unizony 1Martin Aringer 3Daniel Blockmans 4Elisabeth Brouwer 5Maria C Cid 6Bhaskar Dasgupta 7Juergen Rech 8Carlo Salvarani 9Robert Spiera 10Min Bao 11

12

Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients' Outcomes

Curr Rheumatol Rep. 2022 Aug;24(8):259-267. doi: 10.1007/s11926-022-01078-2.Epub 2022 Jul 7.

 

Kelly Sun 1Jolene H Fisher 1Christian Pagnoux 2

13

Journal Club Review of "Avacopan for the Treatment of ANCA-Associated Vasculitis"

ACR Open Rheumatol. 2022 Jul;4(7):558-561. doi: 10.1002/acr2.11412. Epub 2022 Feb 15.

 

William Daniel Soulsby 1

14

ANCA associated vasculitis (AAV): a review for internists

Postgrad Med. 2022 Jul 21;1-11. doi: 10.1080/00325481.2022.2102368.Online ahead of print.

 

Kinanah Yaseen 1Brian F Mandell 1

15

Vasculitis: What Have We Learned in the Last 50 Years?

J Rheumatol. 2022 Jul;49(7):848-852. doi: 10.3899/jrheum.220207. Epub 2022 May 15.

 

Simon Carette 1

16

Polyarteritis nodosa: an evolving primary systemic vasculitis

Postgrad Med. 2022 Jun 22;1-8. doi: 10.1080/00325481.2022.2088940.Online ahead of print.

 

Jason M Springer 1Kevin Byram 1

17

Cranial giant cell arteritis mimickers: A masquerade to unveil

Autoimmun Rev. 2022 May;21(5):103083. doi: 10.1016/j.autrev.2022.103083.Epub 2022 Mar 24.

 

Gerasimos Evangelatos 1Alexandros Grivas 2Maria Pappa 3Konstantina Kouna 4Alexios Iliopoulos 4George E Fragoulis 3

18

Mechanisms of vascular damage in ANCA vasculitis

Semin Immunopathol. 2022 May;44(3):325-345.doi: 10.1007/s00281-022-00920-0. Epub 2022 Mar 7.

 

David Massicotte-Azarniouch 1Carolina A Herrera 1 2J Charles Jennette 2Ronald J Falk 1Meghan E Free 3

19

How the availability of anti-C5a agents could change the management of ANCA-associated Vasculitis

Kidney Blood Press Res. 2022 Jun 3. doi: 10.1159/000525357. Online ahead of print.

Dario RoccatelloRoberta FenoglioValentina OddoneSavino Sciascia

20

Therapeutic advances in eosinophilic granulomatosis with polyangiitis

Curr Opin Rheumatol. 2022 May 1;34(3):158-164.doi: 10.1097/BOR.0000000000000873. Epub 2022 Apr 18.

 

Julia A Ford 1Yaseen AleatanyOra Gewurz-Singer

21

Tocilizumab for giant cell arteritis

Cochrane Database Syst Rev. 2022 May 13;5(5):CD013484.doi: 10.1002/14651858.CD013484.pub3.

 

Aileen A Antonio 1Ronel N Santos 1Samuel A Abariga 2

22

Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study

Arthritis Res Ther. 2022 Jun 4;24(1):133. doi: 10.1186/s13075-022-02815-9.

 

Christophe Schmitt 1Laura Brockwell 2Mylène Giraudon 3Mauro Zucchetto 4Lisa Christ 5Bettina Bannert 6Thomas Daikeler # 6Peter M Villiger # 7

23

Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review

Front Med (Lausanne). 2022 May 12;9:824630. doi: 10.3389/fmed.2022.824630.eCollection 2022.

 

Alberto Lo Gullo 1Clemente Giuffrida 2Carmela Morace 3Giovanni Squadrito 3Paola Magnano San Lio 4Luisa Ricciardi 5Carlo Salvarani 6Giuseppe Mandraffino 3

24

Sjögren syndrome overlapping with ANCA-associated vasculitis: Four additional cases and systematic literature review

Autoimmun Rev. 2022 Jun;21(6):103099. doi: 10.1016/j.autrev.2022.103099.Epub 2022 Apr 19.

 

Cyrille Coustal 1Béatrice Guillope 2Chris Serrand 3Jacques Morel 4Guillaume Taieb 5Elodie Castille 1Kaoutar Meliani 1Olivier Darmon 1Radjiv Goulabchand 6Philippe Guilpain 7

25

Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

J Clin Med. 2022 May 4;11(9):2573. doi: 10.3390/jcm11092573.

 

Rocío Redondo-Rodriguez 1Natalia Mena-Vázquez 1Alba María Cabezas-Lucena 1Sara Manrique-Arija 1 2Arkaitz Mucientes 1Antonio Fernández-Nebro 1 2

26

The role of neutrophils in rheumatic disease-associated vascular inflammation

Nat Rev Rheumatol. 2022 Mar;18(3):158-170. doi: 10.1038/s41584-021-00738-4.Epub 2022 Jan 17.

 

Lihui Wang 1Raashid Luqmani 2Irina A Udalova 3

27

A systematic review of clinical and preclinical evidences for Janus kinase inhibitors in large vessel vasculitis

Clin Rheumatol. 2022 Jan;41(1):33-44. doi: 10.1007/s10067-021-05973-4.Epub 2021 Nov 3.

 

Upendra Rathore 1Darpan Radheshyam Thakare 1Pallavi Patro 2Vikas Agarwal 1Aman Sharma 3Durga Prasanna Misra 4

28

Endovascular Therapy for Intracranial Giant Cell Arteritis : Systematic Review, Technical Considerations and the Effect of Intra-arterial Calcium Channel Blockers

Clin Neuroradiol. 2022 May 3. doi: 10.1007/s00062-022-01171-0. Online ahead of print.

 

M Travis Caton Jr 1Ian T Mark 2Kazim H Narsinh 2Amanda Baker 2Daniel L Cooke 2Steven W Hetts 2Christopher F Dowd 2Van V Halbach 2Randall T Higashida 2Nerissa U Ko 3Sharon A Chung 4Matthew R Amans 2

29

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Toward an Individualized Approach

Nephron. 2022;146(2):121-137. doi: 10.1159/000520727. Epub 2021 Dec 15.

 

Javier Villacorta 1Laura Martinez-Valenzuela 2Irene Martin-Capon 1Juliana Bordignon-Draibe 2

30

Journal Club Review of "Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody-Associated Vasculitis: Systematic Review and Meta-Analysis"

ACR Open Rheumatol. 2022 May;4(5):406-409. doi: 10.1002/acr2.11409. Epub 2022 Feb 4.

 

Mohanad Elfishawi 1

31

Psychometric properties of outcome measurement instruments for ANCA-associated vasculitis: a systematic literature review

2022 Mar 16;keac175. doi: 10.1093/rheumatology/keac175.Online ahead of print.

 

Alvise Berti 1Gonçalo Boleto 2Peter A Merkel 3Gunnar Tómasson 4Sara Monti 5Kaitlin A Quinn 6Leslie C Hassett 7Loreto Carmona 8Sofia Ramiro 9OMERACT Vasculitis Working Group

32

Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis

Autoimmun Rev. 2022 Jun;21(6):103100. doi: 10.1016/j.autrev.2022.103100.Epub 2022 Apr 19.

 

Brandon S Walker 1Lisa K Peterson 2Curry Koening 3Sandra K White 4Robert L Schmidt 2Anne E Tebo 5

33

Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders

Front Immunol. 2022 Feb 2;12:788830. doi: 10.3389/fimmu.2021.788830. eCollection 2021.

Celine Kaegi 1Benjamin Wuest 1Catherine Crowley 1Onur Boyman 1 2

34

Alemtuzumab for refractory primary systemic vasculitis-a randomised controlled dose ranging clinical trial of efficacy and safety (ALEVIATE)

Arthritis Res Ther. 2022 Apr 1;24(1):81.doi: 10.1186/s13075-022-02761-6.

 

Seerapani Gopaluni 1Rona Smith 2 3Donna Goymer 3Hugh Cahill 3Elizabeth Broadhurst 3Elizabeth Wallin 3Mark McClure 2 3Afzal Chaudhry 3David Jayne 2 3

35

Inflammatory muscle involvement in systemic vasculitis: A systematic review

Autoimmun Rev. 2022 Mar;21(3):103029. doi: 10.1016/j.autrev.2021.103029.Epub 2021 Dec 29.

 

Edoardo Conticini 1Miriana d'Alessandro 2Suhel Gabriele Al Khayyat 1Roberto D'Alessandro 1Emilio D'Ignazio 1Anna Paola Pata 1Giulia Vallifuoco 1Paolo Falsetti 1Caterina Baldi 1Marco Bardelli 1Stefano Gentileschi 1Claudia Fabiani 3Maria Antonietta Mazzei 4Andrea Guarnieri 5Elena Bargagli 2Luca Cantarini 6Bruno Frediani 1

36

Comparative efficacy and safety of rituximab, mycophenolate, methotrexate, and cyclophosphamide versus azathioprine as maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: A Bayesian network meta-analysis of randomized controlled trials

Int J Clin Pharmacol Ther. 2022 Feb;60(2):97-105. doi: 10.5414/CP204053.

 

Young Ho LeeGwan Gyu Song

37

Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis

Clin Rheumatol. 2022 Jan;41(1):19-31. doi: 10.1007/s10067-021-05819-z.Epub 2021 Aug 20.

 

Alberto Floris 1 2Matteo Piga 3Elisabetta Chessa 3Mattia Congia 3Gian Luca Erre 4Maria Maddalena Angioni 3Alessandro Mathieu 3Alberto Cauli 3

38

Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis

Clin Rheumatol. 2021 Dec;40(12):4829-4836. doi: 10.1007/s10067-021-05783-8.Epub 2021 Jun 23.

 

Rupert W Jakes 1Namhee Kwon 2Beth Nordstrom 3Rebecca Goulding 3Kyle Fahrbach 3Jialu Tarpey 3Melissa K Van Dyke 4

39

A systematic review and meta-analysis of the incidence rate of Takayasu arteritis

Rheumatology (Oxford). 2021 Nov 3;60(11):4982-4990.doi: 10.1093/rheumatology/keab406.

 

Megan Rutter 1 2Jonathan Bowley 1Peter C Lanyon 1 2Matthew J Grainge 1Fiona A Pearce 1 2

40

ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives

J Inflamm Res. 2022 Apr 21;15:2567-2582. doi: 10.2147/JIR.S284768.eCollection 2022.

Keziah Austin # 1Shalini Janagan # 2Matthew Wells 3Helena Crawshaw 4Stephen McAdoo 5Joanna C Robson 2 6

41

Diagnostic and Therapeutic Challenges of Vasculitis

Can J Cardiol. 2022 Feb 11;S0828-282X(22)00125-8.doi: 10.1016/j.cjca.2022.02.007. Online ahead of print.

 

Megan E Hansen 1Jason Springer 1Kevin Byram 2

42

Age as a risk factor in vasculitis

Semin Immunopathol. 2022 Feb 9. doi: 10.1007/s00281-022-00911-1.Online ahead of print.

 

Andrea D Gloor 1Gerald J Berry 2Jorg J Goronzy 1 3Cornelia M Weyand 4 5

43

Clinical Features of ANCA-Associated Vasculitis in African American Patients in the United States: A Single-Center Medical Records Review Study

J Clin Rheumatol. 2022 Mar 21. doi: 10.1097/RHU.0000000000001838. Online ahead of print.

Luis Palomino 1Angelo GaffoDongmei SunSebastian E Sattui

44

Large-vessel vasculitis

Nat Rev Dis Primers. 2022 Jan 6;7(1):93. doi: 10.1038/s41572-021-00327-5.

Dan Pugh 1, Maira Karabayas 2, Neil Basu 3, Maria C Cid 4, Ruchika Goel 5, Carl S Goodyear 3, Peter C Grayson 6, Stephen P McAdoo 7, Justin C Mason 8, Catherine Owen 9, Cornelia M Weyand 10, Taryn Youngstein 8, Neeraj Dhaun 11

45

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis

Arthritis Rheumatol. 2022 Mar;74(3):386-392.doi: 10.1002/art.41982.Epub 2022 Feb 2.

Peter C Grayson 1, Cristina Ponte 2, Ravi Suppiah 3, Joanna C Robson 4, Anthea Craven 5, Andrew Judge 6, Sara Khalid 5, Andrew Hutchings 7, Raashid A Luqmani 5, Richard A Watts 8, Peter A Merkel 9, DCVAS Study Group

DCVAS Study Group: 

Paul Gatenby, Catherine Hill, Dwarakanathan Ranganathan, Andreas Kronbichler, Daniel Blockmans, Lillian Barra, Simon Carette, Christian Pagnoux, Navjot Dhindsa, Aurore Fifi-Mah, Nader Khalidi, Patrick Liang, Nataliya Milman, Christian Pineau, Xinping Tian, Guochun Wang, Tian Wang, Ming-Hui Zhao, Vladimir Tesar, Bo Baslund, Nevin Hammam, Amira Shahin, Laura Pirila, Jukka Putaala, Bernhard Hellmich, Jörg Henes, Peter Lamprecht, Thomas Neumann, Wolfgang Schmidt, Cord Sunderkoetter, Zoltan Szekanecz, Debashish Danda, Siddharth Das, Rajiva Gupta, Liza Rajasekhar, Aman Sharma, Shrikant Wagh, Michael Clarkson, Eamonn Molloy, Carlo Salvarani, Franco Schiavon, Enrico Tombetti, Augusto Vaglio, Koichi Amano, Yoshihiro Arimura, Hiroaki Dobashi, Shouichi Fujimoto, Masayoshi Harigai, Fumio Hirano, Junichi Hirahashi, Sakae Honma, Tamihiro Kawakami, Shigeto Kobayashi, Hajime Kono, Hirofumi Makino, Kazuo Matsui, Eri Muso, Kazuo Suzuki, Kei Ikeda, Tsutomu Takeuchi, Tatsuo Tsukamoto, Shunya Uchida, Takashi Wada, Hidehiro Yamada, Kunihiro Yamagata, Wako Yumura, Kan Sow Lai, Luis Felipe Flores-Suarez, Andrea Hinojosa, Bram Rutgers, Paul-Peter Tak, Rebecca Grainger, Vicki Quincey, Lisa Stamp, Ravi Suppiah, Emilio Besada, Andreas Diamantopoulos, Jan Sznajd, Elsa Azevedo, Ruth Geraldes, Miguel Rodrigues, Ernestina Santos, Yeong-Wook Song, Sergey Moiseev, Alojzija Hoc?evar, Maria Cinta Cid, Xavier Solanich Moreno, Inoshi Atukorala, Ewa Berglin, Aladdin Mohammed, Mårten Segelmark, Thomas Daikeler, Haner Direskeneli, Gulen Hatemi, Sevil Kamali, Ömer Karadag, Seval Pehlevan, Matthew Adler, Neil Basu, Iain Bruce, Kuntal Chakravarty, Bhaskar Dasgupta, Oliver Flossmann, Nagui Gendi, Alaa Hassan, Rachel Hoyles, David Jayne, Colin Jones, Rainer Klocke, Peter Lanyon, Cathy Laversuch, Raashid Luqmani, Joanna Robson, Malgorzata Magliano, Justin Mason, Win Win Maw, Iain McInnes, John Mclaren, Matthew Morgan, Ann Morgan, Chetan Mukhtyar, Edmond O'Riordan, Sanjeev Patel, Adrian Peall, Joanna Robson, Srinivasan Venkatachalam, Erin Vermaak, Ajit Menon, Richard Watts, Chee-Seng Yee, Daniel Albert, Leonard Calabrese, Sharon Chung, Lindsy Forbess, Angelo Gaffo, Ora Gewurz-Singer, Peter Grayson, Kimberly Liang, Eric Matteson, Peter A Merkel, Jason Springer, Antoine Sreih

46

Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?

Clin Kidney J. 2022 Jan 13;15(4):618-623. doi: 10.1093/ckj/sfac009.eCollection 2022 Apr.

Lauren Floyd 1, Adam D Morris 1, Alexander Woywodt 1, Ajay Dhaygude 1

47

Association of COVID-19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis

Respirol Case Rep. 2021 Dec 27;10(1):e0894. doi: 10.1002/rcr2.894.eCollection 2022 Jan.

Jamie R Felzer 1, Delvise T Fogwe 1, Shaher Samrah 2, Clement J Michet Jr 3, Ulrich Specks 4, Misbah Baqir 4, Aahd F Kubbara 4

48

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis

Arthritis Rheumatol. 2022 Mar;74(3):393-399. doi: 10.1002/art.41986.Epub 2022 Feb 2.

Joanna C Robson 1, Peter C Grayson 2, Cristina Ponte 3, Ravi Suppiah 4, Anthea Craven 5, Andrew Judge 6, Sara Khalid 5, Andrew Hutchings 7, Richard A Watts 8, Peter A Merkel 9, Raashid A Luqmani 5, DCVAS Study Group

DCVAS Study Group: 

Paul Gatenby, Catherine Hill, Dwarakanathan Ranganathan, Andreas Kronbichler, Daniel Blockmans, Lillian Barra, Simon Carette, Christian Pagnoux, Navjot Dhindsa, Aurore Fifi-Mah, Nader Khalidi, Patrick Liang, Nataliya Milman, Christian Pineau, Xinping Tian, Guochun Wang, Tian Wang, Ming-Hui Zhao, Vladimir Tesar, Bo Baslund, Nevin Hammam, Amira Shahin, Laura Pirila, Jukka Putaala, Bernhard Hellmich, Jörg Henes, Peter Lamprecht, Thomas Neumann, Wolfgang Schmidt, Cord Sunderkoetter, Zoltan Szekanecz, Debashish Danda, Siddharth Das, Rajiva Gupta, Liza Rajasekhar, Aman Sharma, Shrikant Wagh, Michael Clarkson, Eamonn Molloy, Carlo Salvarani, Franco Schiavon, Enrico Tombetti, Augusto Vaglio, Koichi Amano, Yoshihiro Arimura, Hiroaki Dobashi, Shouichi Fujimoto, Masayoshi Harigai, Fumio Hirano, Junichi Hirahashi, Sakae Honma, Tamihiro Kawakami, Shigeto Kobayashi, Hajime Kono, Hirofumi Makino, Kazuo Matsui, Eri Muso, Kazuo Suzuki, Kei Ikeda, Tsutomu Takeuchi, Tatsuo Tsukamoto, Shunya Uchida, Takashi Wada, Hidehiro Yamada, Kunihiro Yamagata, Wako Yumura, Kan Sow Lai, Luis Felipe Flores-Suarez, Andrea Hinojosa, Bram Rutgers, Paul-Peter Tak, Rebecca Grainger, Vicki Quincey, Lisa Stamp, Ravi Suppiah, Emilio Besada, Andreas Diamantopoulos, Jan Sznajd, Elsa Azevedo, Ruth Geraldes, Miguel Rodrigues, Ernestina Santos, Yeong-Wook Song, Sergey Moiseev, Alojzija Hoc?evar, Maria Cinta Cid, Xavier Solanich Moreno, Inoshi Atukorala, Ewa Berglin, Aladdin Mohammed, Mårten Segelmark, Thomas Daikeler, Haner Direskeneli, Gulen Hatemi, Sevil Kamali, Ömer Karadag, Seval Pehlevan, Matthew Adler, Neil Basu, Iain Bruce, Kuntal Chakravarty, Bhaskar Dasgupta, Oliver Flossmann, Nagui Gendi, Alaa Hassan, Rachel Hoyles, David Jayne, Colin Jones, Rainer Klocke, Peter Lanyon, Cathy Laversuch, Raashid Luqmani, Joanna Robson, Malgorzata Magliano, Justin Mason, Win Win Maw, Iain McInnes, John Mclaren, Matthew Morgan, Ann Morgan, Chetan Mukhtyar, Edmond O'Riordan, Sanjeev Patel, Adrian Peall, Joanna Robson, Srinivasan Venkatachalam, Erin Vermaak, Ajit Menon, Richard Watts, Chee-Seng Yee, Daniel Albert, Leonard Calabrese, Sharon Chung, Lindsy Forbess, Angelo Gaffo, Ora Gewurz-Singer, Peter Grayson, Kimberly Liang, Eric Matteson, Peter A Merkel, Jason Springer, Antoine Sreih

49

Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

Ann Rheum Dis. 2022 Mar 9;annrheumdis-2021-221865.doi: 10.1136/annrheumdis-2021-221865. Online ahead of print.

Maria C Cid # 1, Sebastian H Unizony # 2, Daniel Blockmans 3, Elisabeth Brouwer 4, Lorenzo Dagna 5 6, Bhaskar Dasgupta 7, Bernhard Hellmich 8, Eamonn Molloy 9, Carlo Salvarani 10 11, Bruce C Trapnell 12, Kenneth J Warrington 13, Ian Wicks 14 15, Manoj Samant 16, Teresa Zhou 16, Lara Pupim 16, John F Paolini 16, KPL-301-C001 Investigators

50

The Clinical Significance of Small Vessel Vasculitis on Temporal Artery Biopsies

J Neuroophthalmol. 2022 Feb 15. doi: 10.1097/WNO.0000000000001505. Online ahead of print.

Julian Quigley 1, Anthony Michael Sammel, Rodger Laurent, Janice Brewer, Edward Hsiao, Geoffrey Schembri, Clare L Fraser

51

Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study

Ann Rheum Dis. 2022 Feb 21;annrheumdis-2021-221961.doi: 10.1136/annrheumdis-2021-221961. Online ahead of print.

Matthew J Koster 1, Cynthia S Crowson 2, Rachel E Giblon 2, Jane M Jaquith 3, Ali Duarte-García 3, Eric L Matteson 3, Cornelia M Weyand 3, Kenneth J Warrington 3

52

Mimickers of Large Vessel Giant Cell Arteritis

J Clin Med. 2022 Jan 19;11(3):495. doi: 10.3390/jcm11030495.

André Ramon 1 2, Hélène Greigert 2 3 4, Paul Ornetti 1 5 6, Bernard Bonnotte 2 3, Maxime Samson 2 3

53

Addressing the transition to a chronic condition: exploring independent adoption of self-management by patients with ANCA-associated vasculitis

Rheumatol Adv Pract. 2021 Nov 4;5(3):rkab075. doi: 10.1093/rap/rkab075. eCollection 2021.

Ian Litchfield 1, Sheila Greenfield 1, Lorraine Harper 1 2, FAB(V) Trial team

54

Patient reported outcomes in systemic vasculitis

Curr Opin Rheumatol. 2022 Jan 1;34(1):33-38.doi: 10.1097/BOR.0000000000000850.

Helena Crawshaw 1, Matthew Wells 2, Keziah Austin 3, Shalini Janagan 4, Joanna C Robson 4 5

55

Hypothyroidism in Vasculitis

Rheumatology (Oxford). 2021 Nov 3;keab817. doi: 10.1093/rheumatology/keab817.Online ahead of print.

Tanaz A Kermani 1, David Cuthbertson 2, Simon Carette 3, Nader A Khalidi 4, Curry L Koening 5, Carol A Langford 6, Carol A McAlear 7, Paul A Monach 8, Larry Moreland 9, Christian Pagnoux 3, Philip Seo 10, Ulrich Specks 11, Antoine Sreih 7, Kenneth J Warrington 12, Peter A Merkel 7, Vasculitis Clinical Research Consortium

56

The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum

Autoimmun Rev. 2021 Dec;20(12):102986. doi: 10.1016/j.autrev.2021.102986.Epub 2021 Oct 28.

Andreas Kronbichler 1, Duvuru Geetha 2, Rona M Smith 3, Allyson C Egan 3, Ingeborg M Bajema 4, Ulf Schönermarck 5, Alfred Mahr 6, Hans-Joachim Anders 5, Annette Bruchfeld 7, Maria C Cid 8, David R W Jayne 3

57

The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis

BMJ. 2022 Feb 25;376:e064604. doi: 10.1136/bmj-2021-064604.

Michael Walsh 1 2 3, David Collister 3 4, Linan Zeng 2 5, Peter A Merkel 6, Charles D Pusey 7, Gordon Guyatt 8 2, Chen Au Peh 9 10, Wladimir Szpirt 11, Toshiko Ito-Hara 12 13, David R W Jayne 14, Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis BMJ Rapid Recommendations Group

58

Updates in ANCA-associated vasculitis

Eur J Rheumatol. 2022 Feb 14. doi: 10.5152/eujrheum.2022.20248. Online ahead of print.

Carolyn Ross 1, Jean-Paul Makhzoum 2, Christian Pagnoux 1

59

Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting Therapy

Front Immunol. 2022 Jan 28;13:834981. doi: 10.3389/fimmu.2022.834981. eCollection 2022.

Paige K Marty 1, Virginia P Van Keulen 1 2, Courtney L Erskine 1 2, Maleeha Shah 1, Amber Hummel 1, Michael Stachowitz 1, Samantha Fatis 1, Dane Granger 3, Matthew S Block 2 4, Alí Duarte-García 5, Kenneth J Warrington 5, Elitza S Theel 3, Xian Zhou 5, Hu Zeng 2 5, Ulrich Specks 1, Patricio Escalante 1, Tobias Peikert 1 2

60

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis

Ann Rheum Dis. 2022 Feb 2;annrheumdis-2021-221795.doi: 10.1136/annrheumdis-2021-221795. Online ahead of print.

Joanna C Robson 1Peter C Grayson 2Cristina Ponte 3Ravi Suppiah 4Anthea Craven 5Andrew Judge 6 7Sara Khalid 5Andrew Hutchings 8Richard A Watts 5 9Peter A Merkel 10Raashid A Luqmani 5DCVAS Investigators

DCVAS Investigators: 

Paul GatenbyCatherine HillDwarakanathan RanganathanAndreas KronbichlerDaniel BlockmansLillian BarraSimon CaretteChristian PagnouxNavjot DhindsaAurore Fifi-MahNader KhalidiPatrick LiangNataliya MilmanChristian PineauXinping TianGuochun WangTian WangMing-Hui ZhaoVladimir TesarBo BaslundNevin HammamAmira ShahinLaura PirilaJukka PutaalaBernhard HellmichJörg HenesPeter LamprechtThomas NeumannWolfgang SchmidtCord SunderkoetterZoltan SzekaneczDebashish DandaSiddharth DasRajiva GuptaLiza RajasekharAman SharmaShrikant WaghMichael ClarksonEamonn MolloyCarlo SalvaraniFranco SchiavonEnrico TombettiAugusto VaglioKoichi AmanoYoshihiro ArimuraHiroaki DobashiShouichi FujimotoMasayoshi HarigaiFumio HiranoJunichi HirahashiSakae HonmaTamihiro KawakamiShigeto KobayashiHajime KonoHirofumi MakinoKazuo MatsuiEri MusoKazuo SuzukiKei IkedaTsutomu TakeuchiTatsuo TsukamotoShunya UchidaTakashi WadaHidehiro YamadaKunihiro YamagataWako YumuraKan Sow LaiLuis Felipe Flores-SuarezAndrea HinojosaBram RutgersPaul-Peter TakRebecca GraingerVicki QuinceyLisa StampRavi SuppiahEmilio BesadaAndreas DiamantopoulosJan SznajdElsa AzevedoRuth GeraldesMiguel RodriguesErnestina SantosYeong-Wook Song

61

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis

Ann Rheum Dis. 2022 Feb 2;annrheumdis-2021-221796.doi: 10.1136/annrheumdis-2021-221796. Online ahead of print.

Ravi Suppiah 1Joanna C Robson 2Peter C Grayson 3Cristina Ponte 4Anthea Craven 5Sara Khalid 5Andrew Judge 6 7Andrew Hutchings 8Peter A Merkel 9Raashid A Luqmani 5Richard A Watts 5 10DCVAS INVESTIGATORS

62

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis

Ann Rheum Dis. 2022 Feb 2;annrheumdis-2021-221794.doi: 10.1136/annrheumdis-2021-221794. Online ahead of print.

Peter C Grayson 1Cristina Ponte 2 3Ravi Suppiah 4Joanna C Robson 5Anthea Craven 6Andrew Judge 6 7Sara Khalid 6Andrew Hutchings 8Raashid A Luqmani 6Richard A Watts 6 9Peter A Merkel 10DCVAS Study Group

63

Management of severe renal disease in anti-neutrophil-cytoplasmic-antibody-associated vasculitis: place of rituximab and plasma exchange?

Rheumatology (Oxford). 2022 Feb 2;keac046. doi: 10.1093/rheumatology/keac046.Online ahead of print.

Pauline Morel 1Alexandre Karras 2Raphaël Porcher 3Xavier Belenfant 4Vincent Audard 5Cédric Rafat 6Guillaume Hanouna 7Séverine Beaudreuil 8Cédric Vilain 9Aurélie Hummel 10Benjamin Terrier 1Evangeline Pillebout 11Matthieu Groh 12Romain Jouenne 13Robin Dhote 14Olivier Fain 15Matthieu Ponsoye 16Nicolas Noel 17Nicolas Limal 18Xavier Puéchal 1Claire Le Jeunne 1Loïc Guillevin 1Luc Mouthon 1Alexis Régent 1French Vasculitis Study Group (FSVG)

64

A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis

Front Immunol. 2022 Jan 12;12:803175. doi: 10.3389/fimmu.2021.803175. eCollection 2021.

Jack Arnold 1Edward M Vital 1 2Shouvik Dass 1 2Aamir Aslam 1 2Andy C Rawstron 3Sinisa Savic 1 2Paul Emery 1 2Md Yuzaiful Md Yusof 1 2

65

Incidence and risk factors of venous thromboembolism in ANCA-associated vasculitis: a metaanalysis and metaregression

Clin Rheumatol. 2021 Jul;40(7):2843-2853.doi: 10.1007/s10067-021-05589-8. Epub 2021 Jan 15.

Panupong Hansrivijit 1Angkawipa Trongtorsak 2Kinjal P Gadhiya 3Kriti Lnu 3Christina T Dimech 3Charat Thongprayoon 4Wisit Cheungpasitporn 4Stewart H Lecker 5

66

New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a claims data study

Rheumatology (Oxford). 2021 Oct 2;60(10):4868-4873.doi: 10.1093/rheumatology/keaa924.

Bernhard Hellmich 1Peter Lamprecht 2Philip Spearpoint 3Dieter Götte 3Angelika Deichmann 4Ina Buchholz 4Matthias P Schönermark 4Peter Rutherford 3

67

Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort study

Rheumatology (Oxford). 2021 Oct 2;60(10):4616-4623. doi: 10.1093/rheumatology/keab057.

Matina Liapi 1David Jayne 2Peter A Merkel 3 4Mårten Segelmark 5Aladdin J Mohammad 1 2

68

Pleuritis and Pericarditis in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

Chest. 2021 Aug;160(2):572-581. doi: 10.1016/j.chest.2021.02.049. Epub 2021 Mar 2.

Gwen E Thompson 1Michael H Bourne Jr 2Marta Casal Moura 3Misbah Baqir 3Rodrigo Cartin-Ceba 4Ashima Makol 5Matthew J Koster 5Kenneth J Warrington 5Bijan J Borah 6Ulrich Specks 7

69

What is the meaning of ANCA positivity in IgG4-related disease?

Oxford). 2021 Aug 2;60(8):3845-3850. doi: 10.1093/rheumatology/keab124.

Eduardo Martín-Nares 1Gabriela Hernandez-Molina 1

70

Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients: Comparison With Idiopathic Pulmonary Fibrosis

J Clin Rheumatol. 2021 Dec 1;27(8):324-330.doi: 10.1097/RHU.0000000000001357.

Minkyung Kwon 1Augustine S Lee 1Isabel Mira-Avendano 1Carlos A Rojas 2Rolf Grage 2Andy Abril 3

71

Comparison of disease activity in patients with ankylosing spondylitis under TNFi or NSAID treatment, is there any difference? An observational study

Reumatol Clin (Engl Ed). 2021 Apr;17(4):192-196. doi: 10.1016/j.reuma.2019.07.005.Epub 2019 Sep 24.

 

Mireia Moreno 1Marta Arévalo 2Marc Zamora 3Caridad Pontes 4Juan Carlos Oliva 5Jordi Gratacós 1

72

Pregnancy outcomes in women with primary systemic vasculitis: a retrospective study

J Matern Fetal Neonatal Med. 2021 Sep;34(17):2771-2777. doi: 10.1080/14767058.2019.1671329.Epub 2019 Oct 1.

Vanessa Nguyen 1 2Danielle Wuebbolt 1 2Christian Pagnoux 3Rohan D'Souza 1

73

Acute ANCA Vasculitis and Asymptomatic COVID-19

Pediatrics. 2021 Apr;147(4):e2020033092. doi: 10.1542/peds.2020-033092.Epub 2021 Jan 20.

Weston T Powell 1 2 3Julie A Campbell 4 2 3Francesca Ross 2Patricia Peña Jiménez 5 2Erin R Rudzinski 6Jane A Dickerson 6

74

Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: A comparative cohort study

Medicine (Baltimore). 2021 Jul 23;100(29):e26733.doi: 10.1097/MD.0000000000026733.

Claudius Speer 1Christine Altenmüller-Walther 1Jan Splitthoff 2Christian Nusshag 1Florian Kälble 1Paula Reichel 1Christian Morath 1Martin Zeier 1Raoul Bergner 2Matthias Schaier 1

75

Reasons for hospitalization and in-hospital mortality for anti-neutrophil cytoplasmic antibody vasculitides: analysis of the National Inpatient Sample

Clin Rheumatol. 2021 Aug 28. doi: 10.1007/s10067-021-05880-8. Online ahead of print.

Mavi Rivera 1A Villafranca 2P Khamooshi 3V Reyes 3J Sanchez 3A Manadan 4

76

ANCA and anti-glomerular basement membrane double-positive patients: A systematic review of the literature

Autoimmun Rev. 2021 Jul 7;20(9):102885. doi: 10.1016/j.autrev.2021.102885.Online ahead of print.

Rémi Philip 1Anael Dumont 2Nicolas Martin Silva 1Hubert de Boysson 2Achille Aouba 3Samuel Deshayes 2

77

Diagnosing Giant Cell Arteritis: A Comprehensive Practical Guide for the Practicing Rheumatologist

Rheumatology (Oxford). 2021 Jul 13;keab547. doi: 10.1093/rheumatology/keab547.Online ahead of print.

Peter M Andel 1 2Stavros Chrysidis 3Julia Geiger 4Anne Haaversen 5Glenn Haugeberg 2 6Geirmund Myklebust 2Berit D Nielsen 7 8Andreas Diamantopoulos 5 9

78

Gastrointestinal involvement in IgA vasculitis: a single-center 11-year study on a cohort of 118 children

Clin Rheumatol. 2021 Jul 17. doi: 10.1007/s10067-021-05863-9. Online ahead of print.

Chiara Rubino 1Costanza Monacelli 2Edoardo Marrani 3Monica Paci 4Giuseppe Indolfi 1 5Gabriele Simonini 3 5Sandra Trapani 6 7

79

Developing a composite outcome tool to measure response to treatment in ANCA-associated vasculitis: A mixed methods study from OMERACT 2020

Semin Arthritis Rheum. 2021 Jul 8;S0049-0172(21)00125-6.doi: 10.1016/j.semarthrit.2021.07.001. Online ahead of print.

Kaitlin A Quinn 1Sara Monti 2Robin Christensen 3David Jayne 4Carol A Langford 5Georgia E Lanier 6Alfred Mahr 7Christian Pagnoux 8Beverley Shea 9Peter Tugwell 10Maria Bjork Viðarsdóttir 11Gunnar Tomasson 12Peter A Merkel 13

80

Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases

Lancet Rheumatol. 2021 Jul 22. doi: 10.1016/S2665-9913(21)00175-2. Online ahead of print.

Jonathan S Hausmann 1 2 3Kevin Kennedy 4Julia F Simard 5Jean W Liew 6Jeffrey A Sparks 7Tarin T Moni 8Carly Harrison 9Maggie J Larché 10Mitchell Levine 4 11 12Sebastian E Sattui 13Teresa Semalulu 11Gary Foster 4 11Salman Surangiwala 14Lehana Thabane 4Richard P Beesley 15 16Karen L Durrant 17Elsa F Mateus 18Serena Mingolla 19Michal Nudel 20Candace A Palmerlee 21Dawn P Richards 22David F L Liew 23Catherine L Hill 24 25Suleman Bhana 26Wendy Costello 27Rebecca Grainger 28Pedro M Machado 29 30 31Philip C Robinson 32Paul Sufka 33Zachary S Wallace 34Jinoos Yazdany 35Emily Sirotich 4 22COVID-19 Global Rheumatology Alliance

81

Management of primary vasculitides with biologic and novel small molecule medications

Curr Opin Rheumatol. 2021 Jan;33(1):8-14. doi: 10.1097/BOR.0000000000000756.

Naomi Serling-Boyd 1Zachary S Wallace 1 2 3

82

Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency

 Front Immunol. 2020 Oct 21;11:574738. doi: 10.3389/fimmu.2020.574738.eCollection 2020.

Christoph B Geier 1Jocelyn R Farmer 2Zsofia Foldvari 3Boglarka Ujhazi 4Jolanda Steininger 1John W Sleasman 5Suhag Parikh 6Meredith A Dilley 7Sung-Yun Pai 8 9 10Lauren Henderson 11Melissa Hazen 11Benedicte Neven 12 13 14Despina Moshous 12 13 15Svetlana O Sharapova 16Snezhina Mihailova 17Petya Yankova 17Elisaveta Naumova 17Seza Özen 18Kevin Byram 19James Fernandez 19Hermann M Wolf 1 20Martha M Eibl 1 21Luigi D Notarangelo 22Leonard H Calabrese 19Jolan E Walter 23 24

83

The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis

Autoimmun Rev. 2021 Jan;20(1):102716. doi: 10.1016/j.autrev.2020.102716.Epub 2020 Nov 13.

Niels A D Guchelaar 1Manon M Waling 1Anviti A Adhin 1Paul L A van Daele 1Marco W J Schreurs 2Saskia M Rombach 3

84

Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study

Rheumatology (Oxford). 2021 Jun 18;60(6):2745-2754. doi: 10.1093/rheumatology/keaa699.

Jens Rathmann 1David Jayne 2Mårten Segelmark 3Göran Jönsson 4Aladdin J Mohammad 1 2

85

Defining a Therapeutic Window for Rituximab Maintenance Therapy in ANCA-Associated Vasculitis: A Longitudinal Observational Study

J Clin Rheumatol. 2020 Dec 15;Publish Ahead of Print:10.1097/RHU.0000000000001688.

doi: 10.1097/RHU.0000000000001688. Online ahead of print.

Jason Michael Springer 1Ryan S Funk

86

Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry

Semin Arthritis Rheum. 2021 Apr;51(2):339-346. doi: 10.1016/j.semarthrit.2021.02.002.Epub 2021 Feb 10.

Michele Iudici 1Christian Pagnoux 2Delphine S Courvoisier 3Pascal Cohen 4Mohamed Hamidou 5Achille Aouba 6François Lifermann 7Marc Ruivard 8Olivier Aumaître 8Bernard Bonnotte 9François Maurier 10Olivier Decaux 11Eric Hachulla 12Alexandre Karras 13Chahéra Khouatra 14Noémie Jourde-Chiche 15Jean-François Viallard 16Claire Blanchard-Delaunay 17Pascal Godmer 18Alain Le Quellec 19Thomas Quéméneur 20Claire de Moreuil 21Alexis Régent 4Benjamin Terrier 4Luc Mouthon 4Loïc Guillevin 4Xavier Puéchal 22French Vasculitis Study Group

87

Pulmonary Low Attenuation Areas on CT in ANCA-associated Vasculitis: A quantitative and semi-quantitative analysis correlated with pulmonary function testing for obstructive airway disease

Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(4):e2020016. doi: 10.36141/svdld.v37i4.9584.Epub 2020 Dec 16.

Christian W Cox 1Brian J Bartholmai 1Misbah Baqir 1Jennifer R Geske 1Ulrich Specks 1

88

Avacopan for the Treatment of ANCA-Associated Vasculitis

 

N Engl J Med. 2021 Feb 18;384(7):599-609. doi: 10.1056/NEJMoa2023386.

David R W Jayne 1Peter A Merkel 1Thomas J Schall 1Pirow Bekker 1ADVOCATE Study Group

 

  • ADVOCATE Study Group

C Au PehA ChakeraB CooperJ KurtkotiD LangguthV LevidiotisG LuxtonP MountD MudgeE NobleR PhoonD RanganathanA RitchieJ RyanM SuranyiA RosenkranzK LhottaA KronbichlerN DemoulinC BovyR HellemansJ HougardyB SprangersK WissingC PagnouxS BarbourS BrachemiS CournoyerL GirardL LaurinP LiangD PhilibertM WalshV TesarR BecvarP HorakI RychlikW SzpirtH DieperinkJ GregersenP IvarsenE KrarupC LyngsoeC RigothierJ AugustoA BelotD ChauveauD CornecN Jourde-ChicheM FicheuxA KarrasA KleinF MaurierR MesbahO MoranneA NeelT QuemeneurD SaadounB TerrierP ZaouiM SchaierU BenckR BergnerM BuschJ FloegeF GrundmannH HallerM HaubitzB HellmichJ HenesB HohensteinC HugoC Iking-KonertF ArndtT KubackiI KotterP LamprechtT LindnerJ HalbritterH MehlingU SchönermarckN VenhoffV VielhauerO WitzkeI SzombatiG SzucsG GaribottoF AlbericiE BrunettaL DagnaS De VitaG EmmiA GabrielliL ManentiF PieruzziD RoccatelloC SalvaraniH DobashiT AtsumiS FujimotoN HaginoA IhataS KanameY KanekoA KatagiriM KatayamaY KirinoK KitagawaA KomatsudaH KonoT KurasawaR MatsumuraT MimuraA MorinobuY MurakawaT NaniwaT NankiN OgawaH OshimaK SadaE SugiyamaT TakeuchiH TakiN TamuraT Tsukamoto

89

ANCA-associated Vasculitis Management in the United States: Data From the Rheumatology Informatics System for Effectiveness (RISE) Registry

J Rheumatol. 2021 Feb 1;jrheum.201330. doi: 10.3899/jrheum.201330. Online ahead of print.

Zachary S Wallace 1Huifeng Yun 1Jeffrey R Curtis 1Lang Chen 1John H Stone 1Hyon K Choi 1

90

Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides

J Clin Med. 2021 May 25;10(11):2299. doi: 10.3390/jcm10112299.

Camille Roubille 1 2Soledad Henriquez 3 4Cédric Mercuzot 1Claire Duflos 5Bertrand Dunogue 3 4Karine Briot 4 6Loic Guillevin 3 4Benjamin Terrier 3 4Pierre Fesler 1 2

91

Interstitial Lung Disease Worsens Short- and Long-Term Outcomes of Systemic Rheumatic Disease Patients Admitted to the ICU: A Multicenter Study

J Clin Med. 2021 Mar 3;10(5):1037. doi: 10.3390/jcm10051037.

Lorrain Banuls 1Juliette Vanoverschelde 2Fanny Garnier 1Matthieu Amalric 1Samir Jaber 3 4Jonathan Charbit 5Kevin Chalard 6Marc Mourad 4 7Nacim Benchabane 1 4Racim Benomar 1Noemie Besnard 1Delphine Daubin 1Vincent Brunot 1Kada Klouche 1 4Romaric Larcher 1 4

92

Renal Arteries Revisited: Anatomy, Pathologic Entities, and Implications for Endovascular Management

Radiographics. May-Jun 2021;41(3):909-928. doi: 10.1148/rg.2021200162.

Richard D White 1Katherine S Moore 1M Ghali Salahia 1W Rhodri Thomas 1Andrew C Gordon 1Ian M Williams 1Andrew M Wood 1Ian A Zealley 1

93

Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now?

 

J Rheumatol. 2021 Mar 1;jrheum.201351. doi: 10.3899/jrheum.201351.Online ahead of print.

David Jayne 1

94

Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis

Rheumatol Int. 2021 Feb;41(2):431-438. doi: 10.1007/s00296-020-04752-9. Epub 2020 Nov 22.

Claudius Speer 1Christine Altenmüller-Walther 2Jan Splitthoff 3Christian Nusshag 2Florian Kälble 2Paula Reichel 2Christian Morath 2Martin Zeier 2Raoul Bergner 3Matthias Schaier 2

95

Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly

Kidney Blood Press Res. 2020;45(6):784-791. doi: 10.1159/000509608.Epub 2020 Oct 12.

Roberta Fenoglio 1Dario Roccatello 2Savino Sciascia 1

96

The role of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis

Clin Rheumatol. 2021 Apr;40(4):1447-1456. doi: 10.1007/s10067-020-05390-z.Epub 2020 Sep 15.

Ioannis Bellos 1Ioannis Michelakis 2Dionysis Nikolopoulos 3 4

97

Small vessel vasculitis secondary to Mycobacterium chelonae

Rheumatol Int. 2020 Sep 5. doi: 10.1007/s00296-020-04697-z.Online ahead of print.

Monica Weinberg 1Ayse Bag-Ozbek 2 3Davina Chen 1Qingping Yao 1

98

Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis?

Front Immunol. 2021 Mar 15;12:635188. doi: 10.3389/fimmu.2021.635188.eCollection 2021.

Kim M O'Sullivan 1Stephen R Holdsworth 1 2 3

99

Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study

Rheumatol Int. 2021 Apr 3;1-10. doi: 10.1007/s00296-021-04847-x. Online ahead of print.

Stefanie D Wade 1Vasileios C Kyttaris 2

100

Pregnancy Outcomes in Systemic Vasculitides

Curr Rheumatol Rep. 2020 Aug 26;22(10):63. doi: 10.1007/s11926-020-00940-5.

Carolyn Ross 1Rohan D'Souza 2Christian Pagnoux 3

101

Randomized clinical trials in ANCA-associated vasculitis: a systematic analysis of the WHO - International Clinical Trials Registry Platform

Orphanet J Rare Dis. 2020 May 29;15(1):130. doi: 10.1186/s13023-020-01408-6.

Michele Iudici 1Xavier Puéchal 2Alejandro Brigante 3Ignacio Atal 4Cem Gabay 5

102

Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes

Rheumatology (Oxford). 2021 Feb 1;60(2):617-628. doi: 10.1093/rheumatology/keaa215.

Sara Monti 1 2Anthea Craven 3Catherine Klersy 4Carlomaurizio Montecucco 1Roberto Caporali 1Richard Watts 5Peter A Merkel 6Raashid Luqmani 3DCVAS Collaborators

 

103

ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation

Kidney Int. 2020 Sep;98(3):744-757. doi: 10.1016/j.kint.2020.04.037. Epub 2020 May 21.

Britta E Jones 1Carolina A Herrera 1Christian Agosto-Burgos 1Joshua Starmer 2William A Bass 1Caroline J Poulton 1Lauren Blazek 1Candace D Henderson 1Yichun Hu 1Susan L Hogan 1Peiqi Hu 3Hong Xiao 3Eveline Y Wu 4Dhruti P Chen 1J Charles Jennette 5Meghan E Free 1Ronald J Falk 6Dominic J Ciavatta 7

104

Pathogenesis of ANCA-associated vasculitis: an emerging role for immunometabolism

Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii33-iii41.doi: 10.1093/rheumatology/keaa023.

Emma Leacy 1Gareth Brady 1Mark A Little 1

105

Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis

Rheumatology (Oxford). 2020 Oct 1;59(10):2970-2975.doi: 10.1093/rheumatology/kez621.

Pierre Charles 1 2Agnès Dechartres 3Benjamin Terrier 1Pascal Cohen 1Stanislas Faguer 4Antoine Huart 4Mohamed Hamidou 5Christian Agard 5Bernard Bonnotte 6Maxime Samson 6Alexandre Karras 7Noémie Jourde-Chiche 8François Lifermann 9Pierre Gobert 10Catherine Hanrotel-Saliou 11Pascal Godmer 12Nicolas Martin-Silva 13Grégory Pugnet 14Marie Matignon 15Olivier Aumaitre 16Jean-François Viallard 17François Maurier 18Nadine Meaux-Ruault 19Sophie Rivière 20Jean Sibilia 21Xavier Puéchal 1Luc Mouthon 1Loïc Guillevin 1French Vasculitis Study Group

106

Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

JAMA Intern Med. 2020 Jun 1;180(6):870-876.doi: 10.1001/jamainternmed.2020.0675.

Greg McDermott 1Xiaoqing Fu 2 3John H Stone 1 4Rachel Wallwork 1 4Yuqing Zhang 1 2 4 3Hyon K Choi 1 2 4 3Zachary S Wallace 1 2 4 3

107

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

N Engl J Med. 2020 Feb 13;382(7):622-631.doi: 10.1056/NEJMoa1803537.

Michael Walsh 1Peter A Merkel 1Chen-Au Peh 1Wladimir M Szpirt 1Xavier Puéchal 1Shouichi Fujimoto 1Carmel M Hawley 1Nader Khalidi 1Oliver Floßmann 1Ron Wald 1Louis P Girard 1Adeera Levin 1Gina Gregorini 1Lorraine Harper 1William F Clark 1Christian Pagnoux 1Ulrich Specks 1Lucy Smyth 1Vladimir Tesar 1Toshiko Ito-Ihara 1Janak Rashme de Zoysa 1Wojciech Szczeklik 1Luis Felipe Flores-Suárez 1Simon Carette 1Loïc Guillevin 1Charles D Pusey 1Alina L Casian 1Biljana Brezina 1Andrea Mazzetti 1Carol A McAlear 1Elizabeth Broadhurst 1Donna Reidlinger 1Samir Mehta 1Natalie Ives 1David R W Jayne 1PEXIVAS Investigators

 

  • PEXIVAS Investigators

Kathy PaizisGiles WaltersMeg JardineCaroline MiltonAbu IbrahamBrian SilvaMichael DesmondVlado PerkovicJadadeesh KurtkotiEswari VilayurAlan CassShaun SummersFiona BrownJessica RyanPeter KerrEuan NobleGrant LuxtonDavid W MudgeCarmel HawleyDavid W JohnsonChen Au PehRandall J FaullDwarakanathan RanganathanLisa JeffsKathy NichollsPeter HughesBruce CooperNeil BoudvilleSharon FordRobyn LanghamDonna ReidlingerAlicia MorrishSunil V BadveElaine PascoePeta-Anne Paul-BrentLaura RobisonAndrea ValksDaniel BlockmansLiesbet HenckaertsBen SprangersRita SuriSoumeya BrachemiWilliam ClarkAmit GargSimon CaretteChristian PagnouxHeather ReichDavid BarthMichael WalshNader KhalidiGerry CoxAndrea Mazzetti

108

Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 Trial

JMIR Res Protoc. 2020 Apr 7;9(4):e16664. doi: 10.2196/16664.

Peter A Merkel 1 2David R Jayne 3Chao Wang 4Jan Hillson 5Pirow Bekker 5

109

Management of ANCA associated vasculitis

BMJ. 2020 Mar 18;368:m421. doi: 10.1136/bmj.m421.

Zachary S Wallace 1 2 3Eli M Miloslavsky 2 3

110

Complications of therapy for ANCA-associated vasculitis

Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii74-iii78. doi: 10.1093/rheumatology/kez618.

Rona Smith 1 2

111

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?

Front Immunol. 2019 Dec 6;10:2855. doi: 10.3389/fimmu.2019.02855.eCollection 2019.

Zachary S Wallace 1 2 3 4John H Stone 2 3 4

112

All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type

Rheumatology (Oxford). 2020 Sep 1;59(9):2308-2315. doi: 10.1093/rheumatology/kez589.

Zachary S Wallace 1 2 3 4Xiaoqing Fu 1 2 3Tyler Harkness 1 2 3John H Stone 2 3 4Yuqing Zhang 1 2 3 4Hyon Choi 2 3 4

113

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

Nat Commun. 2019 Nov 12;10(1):5120. doi: 10.1038/s41467-019-12515-9.

Paul A Lyons 1 2James E Peters 1 3 4Federico Alberici 1 5 6James Liley 1 7Richard M R Coulson 1William Astle 3 7 8Chiara Baldini 9Francesco Bonatti 10Maria C Cid 11Heather Elding 12 13Giacomo Emmi 14Jörg Epplen 15Loïc Guillevin 16David R W Jayne 1Tao Jiang 3Iva Gunnarsson 17Peter Lamprecht 18Stephen Leslie 19 20Mark A Little 21Davide Martorana 10Frank Moosig 22Thomas Neumann 23 24Sophie Ohlsson 25Stefanie Quickert 23 26Giuseppe A Ramirez 27Barbara Rewerska 28Georg Schett 29Renato A Sinico 30Wojciech Szczeklik 28Vladimir Tesar 31Damjan Vukcevic 19 20European Vasculitis Genetics ConsortiumBenjamin Terrier 16Richard A Watts 32 33Augusto Vaglio 34Julia U Holle 22Chris Wallace 1 2 7Kenneth G C Smith 35 36

 

Collaborators

European Vasculitis Genetics Consortium: Mohammed AkilJonathan BarrattNeil BasuAdam S ButterworthIan BruceMichael ClarksonNiall ConlonBhaskar DasGuptaTimothy W R DoultonGeorgina Espígol-FrigoléOliver FlossmannArmando GabrielliJolanta GasiorGina GregoriniGiuseppe GuidaJosé Hernández-RodríguezZdenka HruskovaAmy HudsonAnn KnightPeter LanyonRaashid LuqmaniMalgorzata MaglianoAngelo A ManfrediChristopher MarguerieFederica MaritatiChiara MarvisiNeil J McHughEamonn MolloyAllan MotyerChetan MukhtyarLeonid PadyukovAlberto PesciSergio Prieto-GonzalezMarc Ramentol-SintasPetra ReisDario Roccatello

114

Long-term outcomes in elderly patients with ANCA-associated vasculitis

Rheumatology (Oxford). 2020 May 1;59(5):1076-1083. doi: 10.1093/rheumatology/kez388.

Dominic McGovern 1Sam P Williams 1Katrina Parsons 2Tariq E Farrah 1 3Peter J Gallacher 1 3Eve Miller-Hodges 1 3David C Kluth 1Robert W Hunter 1 3Neeraj Dhaun 1 3

115

Therapeutic options for patients with rare rheumatic diseases: a systematic review and meta-analysis

Orphanet J Rare Dis. 2020 Oct 31;15(1):308. doi: 10.1186/s13023-020-01576-5.

Tim T A Bender 1Judith Leyens 2Julia Sellin 1Dmitrij Kravchenko 3Rupert Conrad 4Martin Mücke 5Matthias F Seidel 6

116

Complementary Use of U.S. FDA's Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis

Pharmacotherapy. 2020 Nov;40(11):1099-1107. doi: 10.1002/phar.2468. Epub 2020 Nov 8.

Mohamed Mohamoud 1Casie Horgan 2Efe Eworuke 3Elizabeth Dee 2Justin Bohn 2Oren Shapira 2Monica A Munoz 1Danijela Stojanovic 4Veronica Sansing-Foster 5Adebola Ajao 3Lois La Grenade 1

117

Low Utility of Radiological Imaging in Evaluating Cutaneous Small-Vessel Vasculitis: A Multi-institutional Retrospective Study

J Am Acad Dermatol. 2020 Oct 1;S0190-9622(20)32644-X. doi: 10.1016/j.jaad.2020.09.051.Online ahead of print.

Andrew C Walls 1Ryan S Din 1Jean-Phillip Okhovat 2Peter B Chansky 3Robert G Micheletti 3Arash Mostaghimi 1

118

An update on the microbiome in vasculitis

Curr Opin Rheumatol. 2021 Jan;33(1):15-23. doi: 10.1097/BOR.0000000000000758.

Shahna Tariq 1, Alison H Clifford

119

Systemic Lupus Erythematosus-associated Retinal Vasculitis Treated with Adalimumab

Ocul Immunol Inflamm. 2020 Nov 16;1-5. doi: 10.1080/09273948.2020.1828937.Online ahead of print.

Sanjana Kuthyar 1, Alexander C Barnes 1, Javeria Bhawal 2, Joseph Christiansen 1, Jessica G Shantha 1, Steven Yeh 1

120

Environmental risk factors associated with ANCA associated vasculitis: A systematic mapping review

Autoimmun Rev. 2020 Nov;19(11):102660. doi: 10.1016/j.autrev.2020.102660. Epub 2020 Sep 15.

Jennifer Scott 1, Jack Hartnett 1, David Mockler 2, Mark A Little 3

121

Morbidity and Mortality of Large-Vessel Vasculitides

Curr Rheumatol Rep. 2020 Oct 16;22(12):86. doi: 10.1007/s11926-020-00963-y.

Matthew J Koster 1, Kenneth J Warrington 2, Eric L Matteson 2

122

Vasculitis patient journey: a scoping review of patient experiences with vasculitis

Clin Rheumatol. 2020 Sep 30. doi: 10.1007/s10067-020-05398-5.Online ahead of print.

Navjeet Gill 1, Jan Willem Cohen Tervaert 2, Elaine Yacyshyn 3

123

Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

ACR Open Rheumatol. 2020 Nov;2(11):662-671. doi: 10.1002/acr2.11185. Epub 2020 Oct 31.

Peter A Merkel 1, John Niles 2, Richard Jimenez 3, Robert F Spiera 4, Brad H Rovin 5, Andrew Bomback 6, Christian Pagnoux 7, Antonia Potarca 8, Thomas J Schall 8, Pirow Bekker 8, CLASSIC Investigators

Collaborators

  • CLASSIC Investigators: 

Louis-Philippe Girard, Yih Chang Chen Lin, Galina Marder, Jennifer Murphy, William Shergy, Christopher Charles Striebich, Areena Swarup, James Tumlin

124

CanVasc consensus recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitis: 2020 update

J Rheumatol. 2020 Sep 15;jrheum.200721. doi: 10.3899/jrheum.200721. Online ahead of print.

Arielle Mendel 1, Daniel Ennis 1, Ellen Go 1, Volodko Bakowsky 1, Corisande Baldwin 1, Susanne M Benseler 1, David A Cabral 1, Simon Carette 1, Marie Clements-Baker 1, Alison Clifford 1, Jan Willem Cohen Tervaert 1, Gerard Cox 1, Natasha Dehghan 1, Christine Dipchand 1, Navjot Dhindsa 1, Leilani Famorca 1, Aurore Fifi-Mah 1, Stephanie Garner 1, Louis-Philippe Girard 1, Clode Lessard 1, Patrick Liang 1, Damien Noone 1, Jean-Paul Makhzoum 1, Nataliya Milman 1, Christian A Pineau 1, Heather N Reich 1, Maxime Rhéaume 1, David B Robinson 1, Dax G Rumsey 1, Tanveer E Towheed 1, Judith Trudeau 1, Marinka Twilt 1, Elaine Yacyshyn 1, Rae Yeung 1, Lillian Barra 1, Nader Khalidi 1, Christian Pagnoux 1

125

Use and reporting of outcome measures in randomized trials for anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic literature review of randomized trials

Semin Arthritis Rheum. 2020 Sep 29;50(6):1314-1325.doi: 10.1016/j.semarthrit.2020.09.010. Online ahead of print.

Sara Monti 1, Kaitlin A Quinn 2, Robin Christensen 3, David Jayne 4, Carol Langford 5, Georgia E Lanier 6, Alfred Mahr 7, Christian Pagnoux 8, Maria Bjork Viðarsdóttir 9, Peter A Merkel 10, Gunnar Tomasson 11

126

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis

Front Immunol. 2020 Sep 3;11:2053. doi: 10.3389/fimmu.2020.02053. eCollection 2020.

Gwen E Thompson 1 2, Lynn A Fussner 3, Amber M Hummel 2, Darrell R Schroeder 2, Francisco Silva 4, Melissa R Snyder 2, Carol A Langford 5, Peter A Merkel 6 7, Paul A Monach 8, Philip Seo 9, Robert F Spiera 10, E William St Clair 11, John H Stone 12, Ulrich Specks 2

127

ANCA-associated vasculitis

Nat Rev Dis Primers. 2020 Aug 27;6(1):71. doi: 10.1038/s41572-020-0204-y.

A Richard Kitching 1 2, Hans-Joachim Anders 3, Neil Basu 4, Elisabeth Brouwer 5, Jennifer Gordon 6, David R Jayne 7, Joyce Kullman 8, Paul A Lyons 7 9, Peter A Merkel 10, Caroline O S Savage 11, Ulrich Specks 12, Renate Kain 13

128

ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenance

Presse Med. 2020 Jul 6;49(3):104031. doi: 10.1016/j.lpm.2020.104031. Online ahead of print.

Benjamin Terrier 1, Pierre Charles 2, Olivier Aumaître 3, Alexandre Belot 4, Bernard Bonnotte 5, Yoann Crabol 6, Cécile-Audrey Durel 7, Mikael Ebbo 8, Noémie Jourde-Chiche 9, Jean-Christophe Lega 10, Xavier Puéchal 11, Grégory Pugnet 12, Thomas Quemeneur 13, Camillo Ribi 14, Maxime Samson 4, Frédéric Vandergheynst 15, Loïc Guillevin 11, French Vasculitis Study Group

129

2020 international consensus on ANCA testing beyond systemic vasculitis

Autoimmun Rev. 2020 Sep;19(9):102618. doi: 10.1016/j.autrev.2020.102618.Epub 2020 Jul 12.

Sergey Moiseev 1, Jan Willem Cohen Tervaert 2, Yoshihiro Arimura 3, Dimitrios P Bogdanos 4, Elena Csernok 5, Jan Damoiseaux 6, Marc Ferrante 7, Luis Felipe Flores-Suárez 8, Marvin J Fritzler 9, Pietro Invernizzi 10, David Jayne 11, J Charles Jennette 12, Mark A Little 13, Stephen P McAdoo 14, Pavel Novikov 15, Charles D Pusey 14, Antonella Radice 16, Alan D Salama 17, Judith A Savige 18, Mårten Segelmark 19, Yehuda Shoenfeld 20, Renato A Sinico 21, Maria-José Sousa 22, Ulrich Specks 23, Benjamin Terrier 24, Athanasios G Tzioufas 25, Severine Vermeire 7, Ming-Hui Zhao 26, Xavier Bossuyt 27

130

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

Ann Rheum Dis. 2020 Jun 24;annrheumdis-2019-216863.doi: 10.1136/annrheumdis-2019-216863. Online ahead of print.

Rona M Smith 1 2, Rachel Bronwen Jones 2, Ulrich Specks 3, Simon Bond 4, Marianna Nodale 4, Reem Aljayyousi 5, Jacqueline Andrews 6, Annette Bruchfeld 7, Brian Camilleri 8, Simon Carette 9, Chee Kay Cheung 10, Vimal Derebail 11, Tim Doulton 12, Lindsy Forbess 13, Shouichi Fujimoto 14, Shunsuke Furuta 15, Ora Gewurz-Singer 16, Lorraine Harper 17, Toshiko Ito-Ihara 18, Nader Khalidi 19, Rainer Klocke 20, Curry Koening 21, Yoshinori Komagata 22, Carol Langford 23, Peter Lanyon 24, Raashid Ahmed Luqmani 25, Hirofumi Makino 26, Carole McAlear 27, Paul Monach 28, Larry W Moreland 29, Kim Mynard 2, Patrick Nachman 11, Christian Pagnoux 30, Fiona Pearce 31, Chen Au Peh 32, Charles Pusey 33, Dwarakanathan Ranganathan 34, Rennie L Rhee 35, Robert Spiera 36, Antoine G Sreih 37, Vladimir Tesar 38, Giles Walters 39, Michael H Weisman 13, Caroline Wroe 40, Peter Merkel 41, David Jayne 42 2, RITAZAREM coinvestigators; RITAZAREM co-investigators

 

Collaborators

Y Arimura, M Clarkson, J de Zoysa, T Endo, Y Hamano, H Kono, S Lawman, E Muso, K Sada, R Smith, K Suzuki, T Tsukamoto, S Uchida, A Vaglio, R Watts

131

Epidemiology, Time-trends and Outcomes of Serious Infections in Patients With Vasculitis: A 19-year National Study

Arthritis Care Res (Hoboken). 2020 Jun 11.doi: 10.1002/acr.24348. Online ahead of print.

Jasvinder A Singh 1 2 3, John D Cleveland 2

132

Utility of the Brief Illness Perception Questionnaire to Monitor Patient Beliefs in Systemic Vasculitis

Rheumatol. 2020 Apr 1;jrheum.190828. doi: 10.3899/jrheum.190828. Online ahead of print.

Mollie N Schwartz 1, Casey A Rimland 1, Kaitlin A Quinn 1, Marcela Ferrada 1, K Bates Gribbons 1, Joel S Rosenblum 1, Wendy Goodspeed 1, Elaine Novakovich 1, Peter C Grayson 1

133

Treatment Outcomes of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Patients Over Age 75 Years: A Meta-Analysis

Morris AD1, Elsayed ME2, Ponnusamy A2, Rowbottom A3, Martin F4, Geetha D5, Dhaygude AP2. Am J Nephrol. 2020 Mar 11:1-9. doi: 10.1159/000506532. [Epub ahead of print]

134

Complications of therapy for ANCA-associated vasculitis

Smith R1,2. Rheumatology (Oxford). 2020 Jan 20. pii: kez618. doi: 10.1093/rheumatology/kez618. [Epub ahead of print]

135

All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type

Wallace ZS1,2,3,4, Fu X1,2,3, Harkness T1,2,3, Stone JH2,3,4, Zhang Y1,2,3,4, Choi H2,3,4. Rheumatology (Oxford). 2019 Dec 17. pii: kez589. doi: 10.1093/rheumatology/kez589. [Epub ahead of print]

136

Long-term outcomes in elderly patients with ANCA-associated vasculitis

McGovern D1, Williams SP1, Parsons K2, Farrah TE1,3, Gallacher PJ1,3, Miller-Hodges E1,3, Kluth DC1, Hunter RW1,3, Dhaun N1,3. Rheumatology (Oxford). 2019 Sep 17. pii: kez388. doi: 10.1093/rheumatology/kez388. [Epub ahead of print]

137

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?

Wallace ZS1,2,3,4, Stone JH2,3,4. Front Immunol. 2019 Dec 6;10:2855. doi: 10.3389/fimmu.2019.02855. eCollection 2019.

138

Anti-neutrophil Cytoplasmic Antibodies (ANCA) as Disease Activity Biomarkers in a "Personalized Medicine Approach" in ANCA-Associated Vasculitis

Osman MS1, Tervaert JWC2. Curr Rheumatol Rep. 2019 Dec 26;21(12):76. doi: 10.1007/s11926-019-0872-3.

139

Remission maintenance in ANCA-associated vasculitis: does one size fit all?

Berti A1,2, Specks U2. Expert Rev Clin Immunol. 2019 Dec;15(12):1273-1286. doi: 10.1080/1744666X.2020.1693260. Epub 2019 Nov 24.